Targeted Therapy for Cancer Treatment

What Is Targeted Therapy?

Targeted therapy is a type of precision medicine that uses drugs to block specific proteins or genes that help cancer cells grow. Doctors must first analyze the tumor’s genetic makeup to determine if a patient is a good candidate for this treatment.

Gene-Based Precision Therapy

This therapy precisely inhibits cancer cell growth pathways based on specific tumor gene mutation targets. Specifically, it is frequently indicated for non-small cell lung cancer, breast cancer, colorectal cancer, and liver cancer.

Furthermore, it is highly suitable for patients with mutations identified through genetic testing, such as EGFR, ALK, or VEGF mutations. Ultimately, the clinical goal is the targeted control of tumor progression and the prolongation of survival.

Molecular Testing Devices

To determine if targeted therapy is an option, doctors use advanced molecular testing devices, including the Beckman Biochemical Analyzer and Immunohistochemistry Testing Platform.

Therefore, these devices detect tumor biomarkers (such as AFP, CEA, and CA125) and crucial gene mutations. Consequently, this testing is essential for patients requiring targeted therapy screening or ongoing efficacy monitoring during their treatment.

Next Steps for Your Case

A hospital introduction cannot determine which care is appropriate for you. Suitability for targeted therapy depends entirely on the individual case and genetic testing results, which are assessed by the treating doctors.

If you would like to explore how targeted therapy can support your treatment plan, the first step is a specialist review. Our team helps coordinate the submission of your medical records to the treating oncologists for an official assessment.